BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 12944917)

  • 21. The p53 family member genes are involved in the Notch signal pathway.
    Sasaki Y; Ishida S; Morimoto I; Yamashita T; Kojima T; Kihara C; Tanaka T; Imai K; Nakamura Y; Tokino T
    J Biol Chem; 2002 Jan; 277(1):719-24. PubMed ID: 11641404
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of DeltaN isoform and polyadenylation site choice variants in molluscan p63/p73-like homologues.
    Muttray AF; Cox RL; Reinisch CL; Baldwin SA
    Mar Biotechnol (NY); 2007; 9(2):217-30. PubMed ID: 17242983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The p53/p63/p73 family of transcription factors: overlapping and distinct functions.
    Levrero M; De Laurenzi V; Costanzo A; Gong J; Wang JY; Melino G
    J Cell Sci; 2000 May; 113 ( Pt 10)():1661-70. PubMed ID: 10769197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. p63 and p73 do not contribute to p53-mediated lymphoma suppressor activity in vivo.
    Perez-Losada J; Wu D; DelRosario R; Balmain A; Mao JH
    Oncogene; 2005 Aug; 24(35):5521-4. PubMed ID: 16007185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p63alpha and DeltaNp63alpha can induce cell cycle arrest and apoptosis and differentially regulate p53 target genes.
    Dohn M; Zhang S; Chen X
    Oncogene; 2001 May; 20(25):3193-205. PubMed ID: 11423969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The guardians of the genome (p53, TA-p73, and TA-p63) are regulators of tumor suppressor miRNAs network.
    Boominathan L
    Cancer Metastasis Rev; 2010 Dec; 29(4):613-39. PubMed ID: 20922462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional regulation of p73 and p63: development and cancer.
    Melino G; Lu X; Gasco M; Crook T; Knight RA
    Trends Biochem Sci; 2003 Dec; 28(12):663-70. PubMed ID: 14659698
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression profiles and functional implications of p53-like transcription factors in thymic epithelial cell subtypes.
    Kikuchi T; Ichimiya S; Kojima T; Crisa L; Koshiba S; Tonooka A; Kondo N; Van Der Saag PT; Yokoyama S; Sato N
    Int Immunol; 2004 Jun; 16(6):831-41. PubMed ID: 15126418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TAp73 and ΔNp73 have opposing roles in 5-aza-2'-deoxycytidine-induced apoptosis in breast cancer cells.
    Lai J; Yang F; Zhang W; Wang Y; Xu J; Song W; Huang G; Gu J; Guan X
    Mol Cells; 2014 Aug; 37(8):605-12. PubMed ID: 25134538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alterations of p63 and p73 in human cancers.
    Inoue K; Fry EA
    Subcell Biochem; 2014; 85():17-40. PubMed ID: 25201187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of pigment epithelium-derived factor as a direct target of the p53 family member genes.
    Sasaki Y; Naishiro Y; Oshima Y; Imai K; Nakamura Y; Tokino T
    Oncogene; 2005 Jul; 24(32):5131-6. PubMed ID: 15856012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TAp63gamma (p51A) and dNp63alpha (p73L), two major isoforms of the p63 gene, exert opposite effects on the vascular endothelial growth factor (VEGF) gene expression.
    Senoo M; Matsumura Y; Habu S
    Oncogene; 2002 Apr; 21(16):2455-65. PubMed ID: 11971180
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evolution of functions within the p53/p63/p73 family.
    De Laurenzi V; Melino G
    Ann N Y Acad Sci; 2000; 926():90-100. PubMed ID: 11193045
    [TBL] [Abstract][Full Text] [Related]  

  • 34. p63 and p73 in human cancer: defining the network.
    Deyoung MP; Ellisen LW
    Oncogene; 2007 Aug; 26(36):5169-83. PubMed ID: 17334395
    [TBL] [Abstract][Full Text] [Related]  

  • 35. P63 in health and cancer.
    Gonfloni S; Caputo V; Iannizzotto V
    Int J Dev Biol; 2015; 59(1-3):87-93. PubMed ID: 26374530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The p53 gene family.
    Kaelin WG
    Oncogene; 1999 Dec; 18(53):7701-5. PubMed ID: 10618710
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The diverse oncogenic and tumour suppressor roles of p63 and p73 in cancer: a review by cancer site.
    Orzol P; Holcakova J; Nekulova M; Nenutil R; Vojtesek B; Coates PJ
    Histol Histopathol; 2015 May; 30(5):503-21. PubMed ID: 25510918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p73 and p63 are homotetramers capable of weak heterotypic interactions with each other but not with p53.
    Davison TS; Vagner C; Kaghad M; Ayed A; Caput D; Arrowsmith CH
    J Biol Chem; 1999 Jun; 274(26):18709-14. PubMed ID: 10373484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain.
    Gaiddon C; Lokshin M; Ahn J; Zhang T; Prives C
    Mol Cell Biol; 2001 Mar; 21(5):1874-87. PubMed ID: 11238924
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress.
    Murray-Zmijewski F; Lane DP; Bourdon JC
    Cell Death Differ; 2006 Jun; 13(6):962-72. PubMed ID: 16601753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.